financial statements
The full income statement, balance sheet, and cash-flow statement for Zimmer Biomet Holdings Inc. (ZBH), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 8.23B YoY+7.2% | 7.68B YoY+3.8% | 7.39B YoY+6.5% | 6.94B YoY+1.6% | 6.83B YoY+11.4% | |
| Cost of revenue | 2.49B YoY+13.8% | 2.19B YoY+5.2% | 2.08B YoY+3.2% | 2.02B YoY+3.0% | 1.96B YoY+7.5% | |
| Research & development | 459M YoY+4.8% | 437M YoY-4.6% | 459M YoY+13.0% | 406M YoY-6.8% | 436M YoY+35.0% | |
| Selling, general & administrative | 3.26B YoY+11.2% | 2.93B YoY+3.2% | 2.84B YoY+2.8% | 2.76B YoY-2.9% | 2.84B YoY+4.8% | |
| Restructuring | — | — | — | — | 32.1M | |
| Amortization of intangibles | 666M YoY+12.5% | 592M YoY+5.4% | 562M YoY+6.6% | 527M YoY-0.5% | 530M YoY+3.4% | |
| Operating income | 1.10B YoY-14.6% | 1.29B YoY+0.6% | 1.28B YoY+83.5% | 696M YoY-19.1% | 860M YoY+935.3% | |
| Net interest income | -293M YoY-34.3% | -218M YoY-8.3% | -201M YoY-22.1% | -165M YoY+20.9% | -208M YoY+1.7% | |
| Other non-operating income | 25.5M YoY+182.0% | -31.1M YoY-234.4% | -9.30M YoY+92.7% | -128M YoY-1149.2% | 12.2M YoY-48.7% | |
| Pre-tax income | 831M YoY-19.9% | 1.04B YoY-2.9% | 1.07B YoY+164.5% | 404M YoY-19.1% | 499M YoY+574.3% | |
| Income tax | 126M YoY-4.3% | 131M YoY+211.4% | 42.2M YoY-62.4% | 112M YoY+109.9% | 53.5M YoY+155.7% | |
705M YoY-22.0% | 904M YoY-11.7% | 1.02B YoY+342.5% | 231M YoY-42.4% | 402M YoY+389.1% | ||
$3.55 YoY-19.9% | $4.43 YoY-9.2% | $4.88 YoY+343.6% | $1.10 YoY-42.4% | $1.91 YoY+385.1% | ||
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
5.12B YoY+9.6% | 4.67B YoY+1.3% | 4.61B YoY+4.1% | 4.43B YoY-9.4% | 4.88B YoY-3.9% | ||
23.1B YoY+8.1% | 21.4B YoY-0.6% | 21.5B YoY+2.0% | 21.1B YoY-10.2% | 23.5B YoY-3.9% | ||
2.58B YoY+5.4% | 2.45B YoY-14.2% | 2.86B YoY+21.2% | 2.36B YoY-32.0% | 3.47B YoY+35.6% | ||
10.4B YoY+16.8% | 8.89B YoY-1.3% | 9.01B YoY-0.3% | 9.04B YoY-16.2% | 10.8B YoY-11.7% | ||
12.7B YoY+1.8% | 12.5B YoY-0.1% | 12.5B YoY+3.8% | 12.0B YoY-5.1% | 12.7B YoY+3.8% | ||
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
1.70B YoY+13.2% | 1.50B YoY-5.2% | 1.58B YoY+16.6% | 1.36B YoY-9.5% | 1.50B YoY+24.5% | ||
-1.98B YoY-122.5% | -888M YoY-14.0% | -779M | — | -504M YoY+18.0% | ||
326M YoY+167.3% | -485M YoY+36.5% | -764M | — | -1.31B YoY-209.6% | ||
| Net change in cash | 66.4M YoY-39.5% | 110M YoY+173.6% | 40.1M YoY+139.0% | -103M YoY+68.2% | -324M YoY-275.7% | |
| Interest paid | 298M YoY+48.6% | 201M YoY+0.1% | 201M YoY+24.1% | 162M YoY-26.2% | 219M YoY+13.4% | |
| Income taxes paid | 377M YoY+14.7% | 329M YoY+52.6% | 215M YoY-34.1% | 327M YoY+26.4% | 258M YoY+82.0% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 17.8B YoY-15.3% | 21.0B YoY-17.3% | 25.4B YoY-4.9% | 26.8B YoY+3.8% | 25.8B YoY-16.9% | |
| P/E | 25.3× YoY+8.6% | 23.3× YoY-56.6% | 53.6× YoY-44.3% | 96.3× YoY+50.0% | 64.2× | |
| P/S | 2.2× YoY-20.9% | 2.7× YoY-21.6% | 3.5× YoY-10.0% | 3.9× YoY+2.8% | 3.8× YoY-14.5% | |
| P/B | 1.4× YoY-16.8% | 1.7× YoY-17.0% | 2.0× YoY-7.0% | 2.2× YoY+7.4% | 2.0× YoY-20.0% | |
| P/FCF | 12.1× YoY-25.4% | 16.2× YoY-39.6% | 26.9× YoY+31.1% | 20.5× YoY+7.9% | 19.0× YoY-33.0% | |
| Earnings yield | 4.0% YoY-7.9% | 4.3% YoY+130.5% | 1.9% YoY+79.5% | 1.0% YoY-33.4% | 1.6% | |
| FCF yield | 8.3% YoY+34.1% | 6.2% YoY+65.7% | 3.7% YoY-23.7% | 4.9% YoY-7.3% | 5.3% YoY+49.3% | |
| Dividend yield | 1.1% YoY+17.5% | 0.9% YoY+15.2% | 0.8% YoY+4.8% | 0.8% YoY-3.3% | 0.8% YoY+21.3% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 8-K |
About this data
Source: ZBH's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ZBH filings on SEC EDGAR → Not investment advice.
